| Khasabov, Sergey G |
University Of Minnesota
United States |
Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling |
5R01CA263777-02 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Alexis Bakos, Ph.D., M.P.H., R.N. |
| King, Suzanne N. |
University Of Louisville
United States |
Mechanisms underlying radiation-induced dysphagia |
1R21CA263107-01A1 |
PAR-20-292 (R21 Clinical Trial Optional) |
Alexis Bakos, Ph.D., M.P.H., R.N. |
| Kleckner, Ian Robert |
University Of Maryland Baltimore
United States |
Effects of exercise during platinum chemotherapy on neuropathy: examining the interoceptive brain system and inflammation |
1R21CA259422-01A1 |
PAR-20-292 (R21 Clinical Trial Optional) |
Marge Good, R.N., M.P.H., O.C.N. |
| Kober, Kord Michael |
University Of California, San Francisco
United States |
An Investigation of the Molecular Mechanisms for and Prediction of the Severity of Cancer Chemotherapy-Related Fatigue Using a Multi-staged Integrated Omics Approach |
3R37CA233774-04S1 |
|
Alexis Bakos, Ph.D., M.P.H., R.N. |
| Kolb, Noah Allan |
University Of Vermont & St Agric College
United States |
Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy |
5R01CA247517-02 |
|
Alexis Bakos, Ph.D., M.P.H., R.N. |
| Krause, Diane S |
Yale University
United States |
"Exploration of Human Parathyroid Cellular Organization and Function" |
1R21CA240660-01A1 |
|
Cecilia Lee, Dr.P.H., R.N. |
| Kroetz, Deanna L |
University Of California, San Francisco
United States |
Contribution of Nuclear S1P Signaling to Microtubule Targeting Agent-Induced Changes in Transcriptional Activity in Human iPS-SNs |
3R01CA261068-02S1 |
|
Alexis Bakos, Ph.D., M.P.H., R.N. |
| Ladas, Elena J. |
Columbia University Health Sciences
United States |
Probiotics for Prevention of Acute Graft-vs-Host Disease in Children with Cancer |
5R01CA201788-07 |
|
Alexis Bakos, Ph.D., M.P.H., R.N. |
| Lee, Richard T |
Beckman Research Institute/City Of Hope
United States |
A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy |
1R21CA260447-01A1 |
PAR-20-292 (R21 Clinical Trial Optional) |
Alexis Bakos, Ph.D., M.P.H., R.N. |
| Levine, Jon David |
University Of California, San Francisco
United States |
Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress |
5R01CA250017-04 |
|
Alexis Bakos, Ph.D., M.P.H., R.N. |